Skip to main content

Zogenix, Inc.

ZGNXDelisted Mar 7, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001375151

Zogenix, Inc. was delisted on Mar 7, 2022; its insiders filed their last Form 4 on Mar 9, 2022; 156 institutions reported holding it in 13F filings for Q4 2021, worth $968.4M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Zogenix, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of ZGNX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1491490
Shares59.1M57.7M−1.41M (−2.4%)
Value$1.02B$876.7M−$145.0M (−14.2%)

New holders (18)

Institutions that held Zogenix, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ZGNX in Q3 2021
InstitutionSharesValue% of portfolio
Redmile Group, LLC1,014,414$15.4M0.27%
HealthInvest Partners AB220,000$3.34M5.01%
Soleus Capital Management, L.P.171,000$2.60M0.40%
International Biotechnology Trust PLC135,000$2.05M0.50%
Creative Planning67,650$1.03M0.00%
SG Americas Securities, LLC31,634$481.0K0.00%
Stanley-Laman Group, Ltd.26,320$400.0K0.05%
Rafferty Asset Management, LLC15,695$238.0K0.00%
Fox Run Management, L.L.C.14,460$220.0K0.14%
Versor Investments LP13,688$208.0K0.01%
Walleye Trading LLC3,779$57.0K0.00%
Dark Forest Capital Management LP1,600$24.0K0.01%
IFP Advisors, Inc685$10.0K0.00%
US Bancorp396$6.00K0.00%
Berman Capital Advisors, LLC175$2.00K0.00%
Kozak & Associates, Inc.35$1.00K0.00%
Rockefeller Capital Management L.P.5$00.00%
Bell Investment Advisors, Inc25$00.00%

Sold out (18)

Institutions that held Zogenix, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.